McKeithan WL, Feyen DAM, Bruyneel AAN, Okolotowicz KJ, et al. Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity. Cell Stem Cell 2020 Sep 12. pii: S1934-5909(20)30399.
PMID: 32931730